Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nothing like that happening here... company is very careful. A little sloppy but still very careful
Patience is the key here and OTC investors don’t have that. Not surprised the PPs is dropping. NP is trying to maintain SP by constant transparency but it’s biopharm. Nothing happens overnight.
Let it fall so I can get better pricing on my shares, lol.
They have a great drug but insufficient infrastructure to meet the demand. That’s the biggest concern right now... can the handle it?
Can they build out the company professionally and to scale?
Let’s hope that’s true. Need professional biz decisions here and IR transparency. If everything that Greg says is true about RXAir this should be at least 50cents right now. But the transparency is horrible in terms of verifiable activity.
There’s otc plays with 250mil debt and zero revs at $3. This is a penny because of horrible IR.
If Greg could just drop any kind of decent news I could alert this and watch it get driven upward. That is if he can hold off and not dilute until 6 cents and above.
All markets are hot right now... people are looking for hot plays. But alas VYST will probably miss that opportunity as well. Smh
Nope, it’s not. But use the news for what it’s worth.
Previous poster said it indirectly. Gilead pays lots of money to keep leronlimab off the market.
... money before humanity as always.
Yep, but now they are about to be embarrassed by Russia (regardless of if it works or not).
Russia is deploying that limab just like AMERICA should have deployed leronlimab.
I wouldn’t doubt it if they read BPs paper and sourced a limab based on the paper.
Would be good to hit NP with this news. Would be better to hit FDA with it, Burnin think they know already. Hence the urgency now.
Yeah, maybe “McCarthyism” will push the FDA to have their own “Limab” ready to go.
Fed Gov does like like being outdone by BRIC countries
However, just about everyone on this Board knew that the world would adopt a limab solution before the USA because the USA is too slow to react. We were just hoping Brazil/Mexico would adopt quicker.
At this point it looks like CytoDyn can’t react fast enough now that the FDA is getting impatient.
Look for NP to start saying he’s moving as fast as he can, looks like FDA isn’t the bottleneck now (with Covid).
Russia registers new Covid-19 drug to keep complication caused by virus ‘under control’ https://www.rt.com/russia/491066-russia-coronavirus-drug-registered/
Seems like the world has the Cydy playbook now.
Only difference is the direction of the market. Hard to make money long when the stock is dropping, lol. Both are natural corrections to the price.
Not an issue but it happens. Most get out within 3-4 hours.
Gotcha. To support your point, this is not the time to short VYST. Although it was back when it popped to 3cents since we all know Greg was bluffing. Lol.
Oh, I’m not talking about VYST right now. There are much better plays daily. Usually a 500% drop happens every day in the pennies. The problem is screening the stocks and finding them. OTC pennies are the best place to short stocks because of the pump and dump volatility. The risk is extreme though.
It’s % based, the actual PPS size doesn’t matter. Say I borrow 1 share at $1, I sell it. Then I buy it back at 50cents and return the shares. I take the 50 cent profit. Multiply that by whatever # of shares you want.
I personally short Naz stocks a lot. It’s easy, especially with the Covid panic. Or you can go long in inverse instruments that go opposite the Dow etc.
Day traders in pennies will “over trade” quite a bit. They’ll sell the news and then short the panic 3-4x a day. That’s not my thing... Plus avoiding the day trading rule with multiple accounts is too much hassle.
Lol, happens every day. EVERY day. $Millions are made doing it.
It’s % based just like long positions. However, a 50% drop is easier than a 100% gain. The risk is greater though since the upside is “unlimited”
Those who know dilution is occurring short with confidence because they know it has to go down.
Seriously? People short pennies every day. It’s hard to find shares to short sometimes and you have to have $25k margin plus $2.50 per share... officially speaking. So it isn’t Joe Dirt out there making a buck that’s for sure.
Ok, we’re pissed. Now what? Lol. It’s a shell company.
I’m ok with the past, he just needs to recognize the future and his shortcomings. Instead of taking all that cash maybe he should have hired an IR person? And/or let Dr. board members do the talking.
Awesome, you want instant results?... you’re in the wrong industry. Can’t sell a drug without FDA approval.
Or better yet have a board member do the show. The new board member would do well.
NP wants the to be in the lights but if he values money he would let someone more qualified do it.
Well, I think you just proved my point. Thanks.
Yep, same here.. ball park.
Yeah, that was the point I was trying to make. He wiffed, I think his next attempt will be more robust.
There’s always the chance Steve will end his games but that not likely.
Lol, yep.
Right? 90% of OTC traders lose 100% of their capital. Happens everyday. Easy money for CEOs in the OTC.
AS doesn’t impact PPs, only OS and float. Float is 1.1B and that’s why it will never hit 15 again.
If Greg can “PROVE” RXAir production then it can go to 6-7 easy. He doesn’t actually have to sell them he just had to trick investors into believing he’s selling them. He wiffed the first time, I think he’s reloading now.
Well, it hit 15 cents on pure BS before... didn’t it?
Lol. Drama. Don’t try that race baiting crap.
This is purely based on his capability to communicate material event effectively and material events show he’s had difficulties.
... you’re making some rather “white “ assumptions about me as well. What makes you think I’m AMERICAN or speak English as a first language?
Take your assumptions and your emotional responses elsewhere.
I agree with that... the shareholder base IMO are Greg’s buddies. They are waiting for the next pump. I don’t think he’s sold any yet. The OS hasn’t shown that yet.
I think they thought the last PR would have went higher and they’re confused why it didn’t. So the next PR will have more ass to it. Next pump should clear 6-7 cents.
Ummm... my post said nothing about “liking”. It comes down to his ability to communicate material events clearly and accurately. The fact that he has to issue PRs to clarify his CCs after “investigations” proved the point. He needs a IR guy and more front office people to handle the business he doesn’t understand.
That’s not what happened. And NP definitely does not have a silver tongue. He’s an aggressive kid out of his league in this market. But he’s gotten them this far, I don’t think he can take it much farther.
Yes, he’s sloppy. He’s not good with English and he’ll get destroyed on a higher tier after uplist.
The technicals don’t show that happening. Something of that size would be noticeable. I think they are holding out for a bigger pump to do that.
I’m shocked the PPS didn’t fall through the floor on the 8k. Perhaps MadeMillions is right and there is a large shareholder base that knows more than the common investor as to what’s coming.
If they are truly selling a lot of commercial RXAir then this has a chance. Who knows?
If I’m Steve I don’t spin this off unless he sees part of the portfolio as useless.
The only hope is that they are selling the chit out of RXAir right now so they can fund many Rotman debacles.
Lol... is this your first time researching a development company? I’ll leave it there...
I’ll reject those options. He’s earning it. He literally resurrected a drug from the trash and now has multiple indications for many diseases plaguing mankind. I’m no fan of him as a public speaker but his hustle and determination is impressive. If leronlimab takes the teeth out of HIV, Cancer, Covid then he could be Time’s man of the year. Not kidding.
Doubtful, I think he missed his chance, it didn’t look like dilution.
That would make sense for them to miss that opportunity, they can’t seem to do anything right.
Would love for them to prove me wrong but they apparently can’t.
Was done to bail out a failing biz. Now the 43% who didn’t approve the deal look foolish.